Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR)

Lignende værker

• Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
  af: Yonekura, Kentro, et al.
  Udgivet: (2015)
• Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
  af: Utsunomiya, Atae, et al.
  Udgivet: (2015)
• Presence of cutaneous lesion is a poor prognostic factor in patients with smoldering-type adult T-cell leukemia-lymphoma
  af: Yonekura, Kentaro, et al.
  Udgivet: (2011)
• Disorders of the cMyb proto-oncogene expression and its significance in the course of ATL development
  af: Nakano, Kazumi, et al.
  Udgivet: (2014)
• Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
  af: Utsunomiya, Atae, et al.
  Udgivet: (2011)